IGC’s Drug Candidate for Alzheimer’s Potentially Presents New Molecular Pathway for THC to Inhibit Aβ40 Production
September 11, 2017 08:00 ET
|
India Globalization Capital
BETHESDA, Md., Sept. 11, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) today provides an update on compelling in vitro data compiled from genetically engineered cell...
IGC’s CEO and Key Scientific Advisor Quoted in “HIGH TIMES” Article on THC and Alzheimer’s Disease
August 03, 2017 06:05 ET
|
India Globalization Capital
BETHESDA, Md., Aug. 03, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) is pleased to announce the publication of “Marijuana Could Help Treat Alzheimer’s: Here’s How It...
IGC Builds Team Adding Industry Leader Dr. Chuanhai Cao, an expert on THC-Based Alzheimer’s Disease Treatments
August 01, 2017 08:41 ET
|
India Globalization Capital
BETHESDA, Md., Aug. 01, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) is pleased to announce that Dr. Chuanhai Cao has joined its medical research team as a key Advisor. ...